Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 473

1.

Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.

Kaplan SA, Gonzalez RR, Te AE.

Eur Urol. 2007 Jun;51(6):1717-23. Epub 2007 Jan 16. Erratum in: Eur Urol. 2008 Jun;53(6):1320.

PMID:
17258855
3.

Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.

Tuncel A, Nalcacioglu V, Ener K, Aslan Y, Aydin O, Atan A.

World J Urol. 2010 Feb;28(1):17-22. doi: 10.1007/s00345-009-0484-z. Epub 2009 Oct 24.

PMID:
19855976
4.

[The positive effect of sildenafil on LUTS from BPH while treating ED].

Ying J, Yao D, Jiang Y, Ren X, Xu M.

Zhonghua Nan Ke Xue. 2004 Sep;10(9):681-3. Chinese.

PMID:
15497711
5.

Sildenafil citrate improves erectile function: a randomised double-blind trial with open-label extension.

McVary KT, Kaufman J, Young JM, Tseng LJ.

Int J Clin Pract. 2007 Nov;61(11):1843-9. Epub 2007 Sep 20.

PMID:
17887993
6.

Efficacy of alfuzosin and sildenafil combination in male patients with lower urinary tract symptoms.

Öztürk Mİ, Kalkan S, Koca O, Güneş M, Akyüz M, Karaman MI.

Andrologia. 2012 May;44 Suppl 1:791-5. doi: 10.1111/j.1439-0272.2011.01268.x. Epub 2011 Dec 23.

PMID:
22211956
7.

A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Stief CG, Porst H, Neuser D, Beneke M, Ulbrich E.

Eur Urol. 2008 Jun;53(6):1236-44. doi: 10.1016/j.eururo.2008.01.075. Epub 2008 Feb 4.

PMID:
18281145
9.
10.

Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.

Vallancien G, Emberton M, Alcaraz A, Matzkin H, van Moorselaar RJ, Hartung R, Harving N, Elhilali M; ALF-ONE Study Group.

BJU Int. 2008 Apr;101(7):847-52. doi: 10.1111/j.1464-410X.2008.07458.x.

11.

Sildenafil citrate improves erectile function and lower urinary tract symptoms independent of baseline body mass index or LUTS severity.

McVary KT, Siegel RL, Carlsson M.

Urology. 2008 Sep;72(3):575-9. doi: 10.1016/j.urology.2008.04.020. Epub 2008 Jul 2.

PMID:
18597830
12.

A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.

Gacci M, Corona G, Salvi M, Vignozzi L, McVary KT, Kaplan SA, Roehrborn CG, Serni S, Mirone V, Carini M, Maggi M.

Eur Urol. 2012 May;61(5):994-1003. doi: 10.1016/j.eururo.2012.02.033. Epub 2012 Feb 25. Review.

PMID:
22405510
13.

Intermittent alpha-blocker therapy in the treatment of men with lower urinary tract symptoms.

Kaplan SA, Reis RB, Cologna A, Suaid HJ, Martins AC, Kohn IJ, Te AE.

Urology. 1998 Jul;52(1):12-6.

PMID:
9671862
14.

Phosphodiesterase-5 inhibitors for lower urinary tract symptoms in men.

Gales BJ, Gales MA.

Ann Pharmacother. 2008 Jan;42(1):111-5. Epub 2007 Dec 19. Review.

PMID:
18094344
15.

Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report.

Liguori G, Trombetta C, De Giorgi G, Pomara G, Maio G, Vecchio D, Ocello G, Ollandini G, Bucci S, Belgrano E.

J Sex Med. 2009 Feb;6(2):544-52. doi: 10.1111/j.1743-6109.2008.01109.x. Epub 2008 Dec 2.

PMID:
19138360
19.

Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.

van Moorselaar RJ, Hartung R, Emberton M, Harving N, Matzkin H, Elhilali M, Alcaraz A, Vallancien G; ALF-ONE Study Group.

BJU Int. 2005 Mar;95(4):603-8.

Supplemental Content

Support Center